Nuclear Medicine Industry Research Report 2024
Summary
Nuclear Medicine?or Radiopharmaceuticals? are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
According to APO Research, The global Nuclear Medicine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Nuclear Medicine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Nuclear Medicine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Nuclear Medicine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of Nuclear Medicine include GE Healthcare, Bracco Imaging, Mallinckrodt, Lantheus Medical Imaging, Bayer, Triad Isotopes, Nordion, Jubilant Pharma and Eli Lilly, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Nuclear Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nuclear Medicine.
The Nuclear Medicine market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nuclear Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nuclear Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Nuclear Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nuclear Medicine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Nuclear Medicine companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
Nuclear Medicine?or Radiopharmaceuticals? are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
According to APO Research, The global Nuclear Medicine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Nuclear Medicine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Nuclear Medicine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Nuclear Medicine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of Nuclear Medicine include GE Healthcare, Bracco Imaging, Mallinckrodt, Lantheus Medical Imaging, Bayer, Triad Isotopes, Nordion, Jubilant Pharma and Eli Lilly, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Nuclear Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nuclear Medicine.
The Nuclear Medicine market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nuclear Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- GE Healthcare
- Bracco Imaging
- Mallinckrodt
- Lantheus Medical Imaging
- Bayer
- Triad Isotopes
- Nordion
- Jubilant Pharma
- Eli Lilly
- SIEMENS
- China Isotope & Radiation
- Dongcheng
- Tc-99
- I-123/131
- In-111
- Xe-133
- Th-201
- Ga-67
- Others
- Diagnostic
- Therapeutic
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nuclear Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Nuclear Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nuclear Medicine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Nuclear Medicine companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
1 PREFACE
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Nuclear Medicine by Type
2.2.1 Market Value Comparison by Type (2019 VS 2023 VS 2030)
2.2.2 Tc-99
2.2.3 I-123/131
2.2.4 In-111
2.2.5 Xe-133
2.2.6 Th-201
2.2.7 Ga-67
2.2.8 Others
2.3 Nuclear Medicine by Application
2.3.1 Market Value Comparison by Application (2019 VS 2023 VS 2030)
2.3.2 Diagnostic
2.3.3 Therapeutic
2.4 Assumptions and Limitations
3 NUCLEAR MEDICINE BREAKDOWN DATA BY TYPE
3.1 Global Nuclear Medicine Historic Market Size by Type (2019-2024)
3.2 Global Nuclear Medicine Forecasted Market Size by Type (2025-2030)
4 NUCLEAR MEDICINE BREAKDOWN DATA BY APPLICATION
4.1 Global Nuclear Medicine Historic Market Size by Application (2019-2024)
4.2 Global Nuclear Medicine Forecasted Market Size by Application (2019-2024)
5 GLOBAL GROWTH TRENDS
5.1 Global Nuclear Medicine Market Perspective (2019-2030)
5.2 Global Nuclear Medicine Growth Trends by Region
5.2.1 Global Nuclear Medicine Market Size by Region: 2019 VS 2023 VS 2030
5.2.2 Nuclear Medicine Historic Market Size by Region (2019-2024)
5.2.3 Nuclear Medicine Forecasted Market Size by Region (2025-2030)
5.3 Nuclear Medicine Market Dynamics
5.3.1 Nuclear Medicine Industry Trends
5.3.2 Nuclear Medicine Market Drivers
5.3.3 Nuclear Medicine Market Challenges
5.3.4 Nuclear Medicine Market Restraints
6 MARKET COMPETITIVE LANDSCAPE BY PLAYERS
6.1 Global Top Nuclear Medicine Players by Revenue
6.1.1 Global Top Nuclear Medicine Players by Revenue (2019-2024)
6.1.2 Global Nuclear Medicine Revenue Market Share by Players (2019-2024)
6.2 Global Nuclear Medicine Industry Players Ranking, 2022 VS 2023 VS 2024
6.3 Global Key Players of Nuclear Medicine Head office and Area Served
6.4 Global Nuclear Medicine Players, Product Type & Application
6.5 Global Nuclear Medicine Players, Date of Enter into This Industry
6.6 Global Nuclear Medicine Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 NORTH AMERICA
7.1 North America Nuclear Medicine Market Size (2019-2030)
7.2 North America Nuclear Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 North America Nuclear Medicine Market Size by Country (2019-2024)
7.4 North America Nuclear Medicine Market Size by Country (2025-2030)
7.5 United States
7.6 Canada
8 EUROPE
8.1 Europe Nuclear Medicine Market Size (2019-2030)
8.2 Europe Nuclear Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Europe Nuclear Medicine Market Size by Country (2019-2024)
8.4 Europe Nuclear Medicine Market Size by Country (2025-2030)
8.5 Germany
8.6 France
8.7 U.K.
8.8 Italy
8.9 Russia
8.10 Nordic Countries
9 ASIA-PACIFIC
9.1 Asia-Pacific Nuclear Medicine Market Size (2019-2030)
9.2 Asia-Pacific Nuclear Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Asia-Pacific Nuclear Medicine Market Size by Country (2019-2024)
9.4 Asia-Pacific Nuclear Medicine Market Size by Country (2025-2030)
9.5 China
9.6 Japan
9.7 South Korea
9.8 Southeast Asia
9.9 India
9.10 Australia
10 LATIN AMERICA
10.1 Latin America Nuclear Medicine Market Size (2019-2030)
10.2 Latin America Nuclear Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Latin America Nuclear Medicine Market Size by Country (2019-2024)
10.4 Latin America Nuclear Medicine Market Size by Country (2025-2030)
10.5 Mexico
10.6 Brazil
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Nuclear Medicine Market Size (2019-2030)
11.2 Middle East & Africa Nuclear Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
11.3 Middle East & Africa Nuclear Medicine Market Size by Country (2019-2024)
11.4 Middle East & Africa Nuclear Medicine Market Size by Country (2025-2030)
11.5 Turkey
11.6 Saudi Arabia
11.7 UAE
12 PLAYERS PROFILED
12.1 GE Healthcare
12.1.1 GE Healthcare Company Information
12.1.2 GE Healthcare Business Overview
12.1.3 GE Healthcare Revenue in Nuclear Medicine Business (2019-2024)
12.1.4 GE Healthcare Nuclear Medicine Product Portfolio
12.1.5 GE Healthcare Recent Developments
12.2 Bracco Imaging
12.2.1 Bracco Imaging Company Information
12.2.2 Bracco Imaging Business Overview
12.2.3 Bracco Imaging Revenue in Nuclear Medicine Business (2019-2024)
12.2.4 Bracco Imaging Nuclear Medicine Product Portfolio
12.2.5 Bracco Imaging Recent Developments
12.3 Mallinckrodt
12.3.1 Mallinckrodt Company Information
12.3.2 Mallinckrodt Business Overview
12.3.3 Mallinckrodt Revenue in Nuclear Medicine Business (2019-2024)
12.3.4 Mallinckrodt Nuclear Medicine Product Portfolio
12.3.5 Mallinckrodt Recent Developments
12.4 Lantheus Medical Imaging
12.4.1 Lantheus Medical Imaging Company Information
12.4.2 Lantheus Medical Imaging Business Overview
12.4.3 Lantheus Medical Imaging Revenue in Nuclear Medicine Business (2019-2024)
12.4.4 Lantheus Medical Imaging Nuclear Medicine Product Portfolio
12.4.5 Lantheus Medical Imaging Recent Developments
12.5 Bayer
12.5.1 Bayer Company Information
12.5.2 Bayer Business Overview
12.5.3 Bayer Revenue in Nuclear Medicine Business (2019-2024)
12.5.4 Bayer Nuclear Medicine Product Portfolio
12.5.5 Bayer Recent Developments
12.6 Triad Isotopes
12.6.1 Triad Isotopes Company Information
12.6.2 Triad Isotopes Business Overview
12.6.3 Triad Isotopes Revenue in Nuclear Medicine Business (2019-2024)
12.6.4 Triad Isotopes Nuclear Medicine Product Portfolio
12.6.5 Triad Isotopes Recent Developments
12.7 Nordion
12.7.1 Nordion Company Information
12.7.2 Nordion Business Overview
12.7.3 Nordion Revenue in Nuclear Medicine Business (2019-2024)
12.7.4 Nordion Nuclear Medicine Product Portfolio
12.7.5 Nordion Recent Developments
12.8 Jubilant Pharma
12.8.1 Jubilant Pharma Company Information
12.8.2 Jubilant Pharma Business Overview
12.8.3 Jubilant Pharma Revenue in Nuclear Medicine Business (2019-2024)
12.8.4 Jubilant Pharma Nuclear Medicine Product Portfolio
12.8.5 Jubilant Pharma Recent Developments
12.9 Eli Lilly
12.9.1 Eli Lilly Company Information
12.9.2 Eli Lilly Business Overview
12.9.3 Eli Lilly Revenue in Nuclear Medicine Business (2019-2024)
12.9.4 Eli Lilly Nuclear Medicine Product Portfolio
12.9.5 Eli Lilly Recent Developments
12.10 SIEMENS
12.10.1 SIEMENS Company Information
12.10.2 SIEMENS Business Overview
12.10.3 SIEMENS Revenue in Nuclear Medicine Business (2019-2024)
12.10.4 SIEMENS Nuclear Medicine Product Portfolio
12.10.5 SIEMENS Recent Developments
12.11 China Isotope & Radiation
12.11.1 China Isotope & Radiation Company Information
12.11.2 China Isotope & Radiation Business Overview
12.11.3 China Isotope & Radiation Revenue in Nuclear Medicine Business (2019-2024)
12.11.4 China Isotope & Radiation Nuclear Medicine Product Portfolio
12.11.5 China Isotope & Radiation Recent Developments
12.12 Dongcheng
12.12.1 Dongcheng Company Information
12.12.2 Dongcheng Business Overview
12.12.3 Dongcheng Revenue in Nuclear Medicine Business (2019-2024)
12.12.4 Dongcheng Nuclear Medicine Product Portfolio
12.12.5 Dongcheng Recent Developments
13 REPORT CONCLUSION
14 DISCLAIMER
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Nuclear Medicine by Type
2.2.1 Market Value Comparison by Type (2019 VS 2023 VS 2030)
2.2.2 Tc-99
2.2.3 I-123/131
2.2.4 In-111
2.2.5 Xe-133
2.2.6 Th-201
2.2.7 Ga-67
2.2.8 Others
2.3 Nuclear Medicine by Application
2.3.1 Market Value Comparison by Application (2019 VS 2023 VS 2030)
2.3.2 Diagnostic
2.3.3 Therapeutic
2.4 Assumptions and Limitations
3 NUCLEAR MEDICINE BREAKDOWN DATA BY TYPE
3.1 Global Nuclear Medicine Historic Market Size by Type (2019-2024)
3.2 Global Nuclear Medicine Forecasted Market Size by Type (2025-2030)
4 NUCLEAR MEDICINE BREAKDOWN DATA BY APPLICATION
4.1 Global Nuclear Medicine Historic Market Size by Application (2019-2024)
4.2 Global Nuclear Medicine Forecasted Market Size by Application (2019-2024)
5 GLOBAL GROWTH TRENDS
5.1 Global Nuclear Medicine Market Perspective (2019-2030)
5.2 Global Nuclear Medicine Growth Trends by Region
5.2.1 Global Nuclear Medicine Market Size by Region: 2019 VS 2023 VS 2030
5.2.2 Nuclear Medicine Historic Market Size by Region (2019-2024)
5.2.3 Nuclear Medicine Forecasted Market Size by Region (2025-2030)
5.3 Nuclear Medicine Market Dynamics
5.3.1 Nuclear Medicine Industry Trends
5.3.2 Nuclear Medicine Market Drivers
5.3.3 Nuclear Medicine Market Challenges
5.3.4 Nuclear Medicine Market Restraints
6 MARKET COMPETITIVE LANDSCAPE BY PLAYERS
6.1 Global Top Nuclear Medicine Players by Revenue
6.1.1 Global Top Nuclear Medicine Players by Revenue (2019-2024)
6.1.2 Global Nuclear Medicine Revenue Market Share by Players (2019-2024)
6.2 Global Nuclear Medicine Industry Players Ranking, 2022 VS 2023 VS 2024
6.3 Global Key Players of Nuclear Medicine Head office and Area Served
6.4 Global Nuclear Medicine Players, Product Type & Application
6.5 Global Nuclear Medicine Players, Date of Enter into This Industry
6.6 Global Nuclear Medicine Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 NORTH AMERICA
7.1 North America Nuclear Medicine Market Size (2019-2030)
7.2 North America Nuclear Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 North America Nuclear Medicine Market Size by Country (2019-2024)
7.4 North America Nuclear Medicine Market Size by Country (2025-2030)
7.5 United States
7.6 Canada
8 EUROPE
8.1 Europe Nuclear Medicine Market Size (2019-2030)
8.2 Europe Nuclear Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Europe Nuclear Medicine Market Size by Country (2019-2024)
8.4 Europe Nuclear Medicine Market Size by Country (2025-2030)
8.5 Germany
8.6 France
8.7 U.K.
8.8 Italy
8.9 Russia
8.10 Nordic Countries
9 ASIA-PACIFIC
9.1 Asia-Pacific Nuclear Medicine Market Size (2019-2030)
9.2 Asia-Pacific Nuclear Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Asia-Pacific Nuclear Medicine Market Size by Country (2019-2024)
9.4 Asia-Pacific Nuclear Medicine Market Size by Country (2025-2030)
9.5 China
9.6 Japan
9.7 South Korea
9.8 Southeast Asia
9.9 India
9.10 Australia
10 LATIN AMERICA
10.1 Latin America Nuclear Medicine Market Size (2019-2030)
10.2 Latin America Nuclear Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Latin America Nuclear Medicine Market Size by Country (2019-2024)
10.4 Latin America Nuclear Medicine Market Size by Country (2025-2030)
10.5 Mexico
10.6 Brazil
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Nuclear Medicine Market Size (2019-2030)
11.2 Middle East & Africa Nuclear Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
11.3 Middle East & Africa Nuclear Medicine Market Size by Country (2019-2024)
11.4 Middle East & Africa Nuclear Medicine Market Size by Country (2025-2030)
11.5 Turkey
11.6 Saudi Arabia
11.7 UAE
12 PLAYERS PROFILED
12.1 GE Healthcare
12.1.1 GE Healthcare Company Information
12.1.2 GE Healthcare Business Overview
12.1.3 GE Healthcare Revenue in Nuclear Medicine Business (2019-2024)
12.1.4 GE Healthcare Nuclear Medicine Product Portfolio
12.1.5 GE Healthcare Recent Developments
12.2 Bracco Imaging
12.2.1 Bracco Imaging Company Information
12.2.2 Bracco Imaging Business Overview
12.2.3 Bracco Imaging Revenue in Nuclear Medicine Business (2019-2024)
12.2.4 Bracco Imaging Nuclear Medicine Product Portfolio
12.2.5 Bracco Imaging Recent Developments
12.3 Mallinckrodt
12.3.1 Mallinckrodt Company Information
12.3.2 Mallinckrodt Business Overview
12.3.3 Mallinckrodt Revenue in Nuclear Medicine Business (2019-2024)
12.3.4 Mallinckrodt Nuclear Medicine Product Portfolio
12.3.5 Mallinckrodt Recent Developments
12.4 Lantheus Medical Imaging
12.4.1 Lantheus Medical Imaging Company Information
12.4.2 Lantheus Medical Imaging Business Overview
12.4.3 Lantheus Medical Imaging Revenue in Nuclear Medicine Business (2019-2024)
12.4.4 Lantheus Medical Imaging Nuclear Medicine Product Portfolio
12.4.5 Lantheus Medical Imaging Recent Developments
12.5 Bayer
12.5.1 Bayer Company Information
12.5.2 Bayer Business Overview
12.5.3 Bayer Revenue in Nuclear Medicine Business (2019-2024)
12.5.4 Bayer Nuclear Medicine Product Portfolio
12.5.5 Bayer Recent Developments
12.6 Triad Isotopes
12.6.1 Triad Isotopes Company Information
12.6.2 Triad Isotopes Business Overview
12.6.3 Triad Isotopes Revenue in Nuclear Medicine Business (2019-2024)
12.6.4 Triad Isotopes Nuclear Medicine Product Portfolio
12.6.5 Triad Isotopes Recent Developments
12.7 Nordion
12.7.1 Nordion Company Information
12.7.2 Nordion Business Overview
12.7.3 Nordion Revenue in Nuclear Medicine Business (2019-2024)
12.7.4 Nordion Nuclear Medicine Product Portfolio
12.7.5 Nordion Recent Developments
12.8 Jubilant Pharma
12.8.1 Jubilant Pharma Company Information
12.8.2 Jubilant Pharma Business Overview
12.8.3 Jubilant Pharma Revenue in Nuclear Medicine Business (2019-2024)
12.8.4 Jubilant Pharma Nuclear Medicine Product Portfolio
12.8.5 Jubilant Pharma Recent Developments
12.9 Eli Lilly
12.9.1 Eli Lilly Company Information
12.9.2 Eli Lilly Business Overview
12.9.3 Eli Lilly Revenue in Nuclear Medicine Business (2019-2024)
12.9.4 Eli Lilly Nuclear Medicine Product Portfolio
12.9.5 Eli Lilly Recent Developments
12.10 SIEMENS
12.10.1 SIEMENS Company Information
12.10.2 SIEMENS Business Overview
12.10.3 SIEMENS Revenue in Nuclear Medicine Business (2019-2024)
12.10.4 SIEMENS Nuclear Medicine Product Portfolio
12.10.5 SIEMENS Recent Developments
12.11 China Isotope & Radiation
12.11.1 China Isotope & Radiation Company Information
12.11.2 China Isotope & Radiation Business Overview
12.11.3 China Isotope & Radiation Revenue in Nuclear Medicine Business (2019-2024)
12.11.4 China Isotope & Radiation Nuclear Medicine Product Portfolio
12.11.5 China Isotope & Radiation Recent Developments
12.12 Dongcheng
12.12.1 Dongcheng Company Information
12.12.2 Dongcheng Business Overview
12.12.3 Dongcheng Revenue in Nuclear Medicine Business (2019-2024)
12.12.4 Dongcheng Nuclear Medicine Product Portfolio
12.12.5 Dongcheng Recent Developments
13 REPORT CONCLUSION
14 DISCLAIMER
LIST OF TABLES
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Nuclear Medicine Market Size by Type (2018-2023) & (US$ Million)
Table 6. Global Nuclear Medicine Revenue Market Share by Type (2018-2023)
Table 7. Global Nuclear Medicine Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 8. Global Nuclear Medicine Revenue Market Share by Type (2024-2029)
Table 9. Global Nuclear Medicine Market Size by Application (2018-2023) & (US$ Million)
Table 10. Global Nuclear Medicine Revenue Market Share by Application (2018-2023)
Table 11. Global Nuclear Medicine Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 12. Global Nuclear Medicine Revenue Market Share by Application (2024-2029)
Table 13. Global Nuclear Medicine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 14. Global Nuclear Medicine Market Size by Region (2018-2023) & (US$ Million)
Table 15. Global Nuclear Medicine Market Share by Region (2018-2023)
Table 16. Global Nuclear Medicine Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 17. Global Nuclear Medicine Market Share by Region (2024-2029)
Table 18. Nuclear Medicine Market Trends
Table 19. Nuclear Medicine Market Drivers
Table 20. Nuclear Medicine Market Challenges
Table 21. Nuclear Medicine Market Restraints
Table 22. Global Top Nuclear Medicine Manufacturers by Revenue (US$ Million) & (2018-2023)
Table 23. Global Nuclear Medicine Revenue Market Share by Manufacturers (2018-2023)
Table 24. Global Nuclear Medicine Industry Manufacturers Ranking, 2021 VS 2022 VS 2023
Table 25. Global Key Players of Nuclear Medicine, Headquarters and Area Served
Table 26. Global Nuclear Medicine Manufacturers, Product Type & Application
Table 27. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Nuclear Medicine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. North America Nuclear Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. North America Nuclear Medicine Market Size by Country (2018-2023) & (US$ Million)
Table 32. North America Nuclear Medicine Market Size by Country (2024-2029) & (US$ Million)
Table 33. Europe Nuclear Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 34. Europe Nuclear Medicine Market Size by Country (2018-2023) & (US$ Million)
Table 35. Europe Nuclear Medicine Market Size by Country (2024-2029) & (US$ Million)
Table 36. Asia-Pacific Nuclear Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 37. Asia-Pacific Nuclear Medicine Market Size by Country (2018-2023) & (US$ Million)
Table 38. Asia-Pacific Nuclear Medicine Market Size by Country (2024-2029) & (US$ Million)
Table 39. Latin America Nuclear Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 40. Latin America Nuclear Medicine Market Size by Country (2018-2023) & (US$ Million)
Table 41. Latin America Nuclear Medicine Market Size by Country (2024-2029) & (US$ Million)
Table 42. Middle East & Africa Nuclear Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 43. Middle East & Africa Nuclear Medicine Market Size by Country (2018-2023) & (US$ Million)
Table 44. Middle East & Africa Nuclear Medicine Market Size by Country (2024-2029) & (US$ Million)
Table 45. GE Healthcare Company Detail
Table 46. GE Healthcare Business Overview
Table 47. GE Healthcare Nuclear Medicine Product
Table 48. GE Healthcare Revenue in Nuclear Medicine Business (2017-2022) & (US$ Million)
Table 49. GE Healthcare Recent Development
Table 50. Bracco Imaging Company Detail
Table 51. Bracco Imaging Business Overview
Table 52. Bracco Imaging Nuclear Medicine Product
Table 53. Bracco Imaging Revenue in Nuclear Medicine Business (2017-2022) & (US$ Million)
Table 54. Bracco Imaging Recent Development
Table 55. Mallinckrodt Company Detail
Table 56. Mallinckrodt Business Overview
Table 57. Mallinckrodt Nuclear Medicine Product
Table 58. Mallinckrodt Revenue in Nuclear Medicine Business (2017-2022) & (US$ Million)
Table 59. Mallinckrodt Recent Development
Table 60. Lantheus Medical Imaging Company Detail
Table 61. Lantheus Medical Imaging Business Overview
Table 62. Lantheus Medical Imaging Nuclear Medicine Product
Table 63. Lantheus Medical Imaging Revenue in Nuclear Medicine Business (2017-2022) & (US$ Million)
Table 64. Lantheus Medical Imaging Recent Development
Table 65. Bayer Company Detail
Table 66. Bayer Business Overview
Table 67. Bayer Nuclear Medicine Product
Table 68. Bayer Revenue in Nuclear Medicine Business (2017-2022) & (US$ Million)
Table 69. Bayer Recent Development
Table 70. Triad Isotopes Company Detail
Table 71. Triad Isotopes Business Overview
Table 72. Triad Isotopes Nuclear Medicine Product
Table 73. Triad Isotopes Revenue in Nuclear Medicine Business (2017-2022) & (US$ Million)
Table 74. Triad Isotopes Recent Development
Table 75. Nordion Company Detail
Table 76. Nordion Business Overview
Table 77. Nordion Nuclear Medicine Product
Table 78. Nordion Revenue in Nuclear Medicine Business (2017-2022) & (US$ Million)
Table 79. Nordion Recent Development
Table 80. Jubilant Pharma Company Detail
Table 81. Jubilant Pharma Business Overview
Table 82. Jubilant Pharma Nuclear Medicine Product
Table 83. Jubilant Pharma Revenue in Nuclear Medicine Business (2017-2022) & (US$ Million)
Table 84. Jubilant Pharma Recent Development
Table 85. Eli Lilly Company Detail
Table 86. Eli Lilly Business Overview
Table 87. Eli Lilly Nuclear Medicine Product
Table 88. Eli Lilly Revenue in Nuclear Medicine Business (2017-2022) & (US$ Million)
Table 89. Eli Lilly Recent Development
Table 90. SIEMENS Company Detail
Table 91. SIEMENS Business Overview
Table 92. SIEMENS Nuclear Medicine Product
Table 93. SIEMENS Revenue in Nuclear Medicine Business (2017-2022) & (US$ Million)
Table 94. SIEMENS Recent Development
Table 95. China Isotope & Radiation Company Detail
Table 96. China Isotope & Radiation Business Overview
Table 97. China Isotope & Radiation Nuclear MedicineProduct
Table 98. China Isotope & Radiation Revenue in Nuclear Medicine Business (2017-2022) & (US$ Million)
Table 99. China Isotope & Radiation Recent Development
Table 100. Dongcheng Company Detail
Table 101. Dongcheng Business Overview
Table 102. Dongcheng Nuclear MedicineProduct
Table 103. Dongcheng Revenue in Nuclear Medicine Business (2017-2022) & (US$ Million)
Table 104. Dongcheng Recent Development
Table 105. GE Healthcare Company Information
Table 106. GE Healthcare Business Overview
Table 107. GE Healthcare Nuclear Medicine Revenue in Nuclear Medicine Business (2018-2023) & (US$ Million)
Table 108. GE Healthcare Revenue in Nuclear Medicine Business (2018-2023) & (US$ Million) Portfolio
Table 109. GE Healthcare Recent Development
Table 110. Bracco Imaging Company Information
Table 111. Bracco Imaging Business Overview
Table 112. Bracco Imaging Nuclear Medicine Revenue in Nuclear Medicine Business (2018-2023) & (US$ Million)
Table 113. Bracco Imaging Revenue in Nuclear Medicine Business (2018-2023) & (US$ Million) Portfolio
Table 114. Bracco Imaging Recent Development
Table 115. Mallinckrodt Company Information
Table 116. Mallinckrodt Business Overview
Table 117. Mallinckrodt Nuclear Medicine Revenue in Nuclear Medicine Business (2018-2023) & (US$ Million)
Table 118. Mallinckrodt Revenue in Nuclear Medicine Business (2018-2023) & (US$ Million) Portfolio
Table 119. Mallinckrodt Recent Development
Table 120. Lantheus Medical Imaging Company Information
Table 121. Lantheus Medical Imaging Business Overview
Table 122. Lantheus Medical Imaging Nuclear Medicine Revenue in Nuclear Medicine Business (2018-2023) & (US$ Million)
Table 123. Lantheus Medical Imaging Revenue in Nuclear Medicine Business (2018-2023) & (US$ Million) Portfolio
Table 124. Lantheus Medical Imaging Recent Development
Table 125. Bayer Company Information
Table 126. Bayer Business Overview
Table 127. Bayer Nuclear Medicine Revenue in Nuclear Medicine Business (2018-2023) & (US$ Million)
Table 128. Bayer Revenue in Nuclear Medicine Business (2018-2023) & (US$ Million) Portfolio
Table 129. Bayer Recent Development
Table 130. Triad Isotopes Company Information
Table 131. Triad Isotopes Business Overview
Table 132. Triad Isotopes Nuclear Medicine Revenue in Nuclear Medicine Business (2018-2023) & (US$ Million)
Table 133. Triad Isotopes Revenue in Nuclear Medicine Business (2018-2023) & (US$ Million) Portfolio
Table 134. Triad Isotopes Recent Development
Table 135. Nordion Company Information
Table 136. Nordion Business Overview
Table 137. Nordion Nuclear Medicine Revenue in Nuclear Medicine Business (2018-2023) & (US$ Million)
Table 138. Nordion Revenue in Nuclear Medicine Business (2018-2023) & (US$ Million) Portfolio
Table 139. Nordion Recent Development
Table 140. Jubilant Pharma Company Information
Table 141. Jubilant Pharma Business Overview
Table 142. Jubilant Pharma Nuclear Medicine Revenue in Nuclear Medicine Business (2018-2023) & (US$ Million)
Table 143. Jubilant Pharma Revenue in Nuclear Medicine Business (2018-2023) & (US$ Million) Portfolio
Table 144. Jubilant Pharma Recent Development
Table 145. Eli Lilly Company Information
Table 146. Eli Lilly Business Overview
Table 147. Eli Lilly Nuclear Medicine Revenue in Nuclear Medicine Business (2018-2023) & (US$ Million)
Table 148. Eli Lilly Revenue in Nuclear Medicine Business (2018-2023) & (US$ Million) Portfolio
Table 149. Eli Lilly Recent Development
Table 150. SIEMENS Company Information
Table 151. SIEMENS Business Overview
Table 152. SIEMENS Nuclear Medicine Revenue in Nuclear Medicine Business (2018-2023) & (US$ Million)
Table 153. SIEMENS Revenue in Nuclear Medicine Business (2018-2023) & (US$ Million) Portfolio
Table 154. SIEMENS Recent Development
Table 155. China Isotope & Radiation Company Information
Table 156. China Isotope & Radiation Business Overview
Table 157. China Isotope & Radiation Nuclear MedicineRevenue in Nuclear Medicine Business (2018-2023) & (US$ Million)
Table 158. China Isotope & Radiation Revenue in Nuclear Medicine Business (2018-2023) & (US$ Million) Portfolio
Table 159. China Isotope & Radiation Recent Development
Table 160. Dongcheng Company Information
Table 161. Dongcheng Business Overview
Table 162. Dongcheng Nuclear MedicineRevenue in Nuclear Medicine Business (2018-2023) & (US$ Million)
Table 163. Dongcheng Revenue in Nuclear Medicine Business (2018-2023) & (US$ Million) Portfolio
Table 164. Dongcheng Recent Development
Table 165. Authors List of This Report
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Nuclear Medicine Market Size by Type (2018-2023) & (US$ Million)
Table 6. Global Nuclear Medicine Revenue Market Share by Type (2018-2023)
Table 7. Global Nuclear Medicine Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 8. Global Nuclear Medicine Revenue Market Share by Type (2024-2029)
Table 9. Global Nuclear Medicine Market Size by Application (2018-2023) & (US$ Million)
Table 10. Global Nuclear Medicine Revenue Market Share by Application (2018-2023)
Table 11. Global Nuclear Medicine Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 12. Global Nuclear Medicine Revenue Market Share by Application (2024-2029)
Table 13. Global Nuclear Medicine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 14. Global Nuclear Medicine Market Size by Region (2018-2023) & (US$ Million)
Table 15. Global Nuclear Medicine Market Share by Region (2018-2023)
Table 16. Global Nuclear Medicine Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 17. Global Nuclear Medicine Market Share by Region (2024-2029)
Table 18. Nuclear Medicine Market Trends
Table 19. Nuclear Medicine Market Drivers
Table 20. Nuclear Medicine Market Challenges
Table 21. Nuclear Medicine Market Restraints
Table 22. Global Top Nuclear Medicine Manufacturers by Revenue (US$ Million) & (2018-2023)
Table 23. Global Nuclear Medicine Revenue Market Share by Manufacturers (2018-2023)
Table 24. Global Nuclear Medicine Industry Manufacturers Ranking, 2021 VS 2022 VS 2023
Table 25. Global Key Players of Nuclear Medicine, Headquarters and Area Served
Table 26. Global Nuclear Medicine Manufacturers, Product Type & Application
Table 27. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Nuclear Medicine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. North America Nuclear Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. North America Nuclear Medicine Market Size by Country (2018-2023) & (US$ Million)
Table 32. North America Nuclear Medicine Market Size by Country (2024-2029) & (US$ Million)
Table 33. Europe Nuclear Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 34. Europe Nuclear Medicine Market Size by Country (2018-2023) & (US$ Million)
Table 35. Europe Nuclear Medicine Market Size by Country (2024-2029) & (US$ Million)
Table 36. Asia-Pacific Nuclear Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 37. Asia-Pacific Nuclear Medicine Market Size by Country (2018-2023) & (US$ Million)
Table 38. Asia-Pacific Nuclear Medicine Market Size by Country (2024-2029) & (US$ Million)
Table 39. Latin America Nuclear Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 40. Latin America Nuclear Medicine Market Size by Country (2018-2023) & (US$ Million)
Table 41. Latin America Nuclear Medicine Market Size by Country (2024-2029) & (US$ Million)
Table 42. Middle East & Africa Nuclear Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 43. Middle East & Africa Nuclear Medicine Market Size by Country (2018-2023) & (US$ Million)
Table 44. Middle East & Africa Nuclear Medicine Market Size by Country (2024-2029) & (US$ Million)
Table 45. GE Healthcare Company Detail
Table 46. GE Healthcare Business Overview
Table 47. GE Healthcare Nuclear Medicine Product
Table 48. GE Healthcare Revenue in Nuclear Medicine Business (2017-2022) & (US$ Million)
Table 49. GE Healthcare Recent Development
Table 50. Bracco Imaging Company Detail
Table 51. Bracco Imaging Business Overview
Table 52. Bracco Imaging Nuclear Medicine Product
Table 53. Bracco Imaging Revenue in Nuclear Medicine Business (2017-2022) & (US$ Million)
Table 54. Bracco Imaging Recent Development
Table 55. Mallinckrodt Company Detail
Table 56. Mallinckrodt Business Overview
Table 57. Mallinckrodt Nuclear Medicine Product
Table 58. Mallinckrodt Revenue in Nuclear Medicine Business (2017-2022) & (US$ Million)
Table 59. Mallinckrodt Recent Development
Table 60. Lantheus Medical Imaging Company Detail
Table 61. Lantheus Medical Imaging Business Overview
Table 62. Lantheus Medical Imaging Nuclear Medicine Product
Table 63. Lantheus Medical Imaging Revenue in Nuclear Medicine Business (2017-2022) & (US$ Million)
Table 64. Lantheus Medical Imaging Recent Development
Table 65. Bayer Company Detail
Table 66. Bayer Business Overview
Table 67. Bayer Nuclear Medicine Product
Table 68. Bayer Revenue in Nuclear Medicine Business (2017-2022) & (US$ Million)
Table 69. Bayer Recent Development
Table 70. Triad Isotopes Company Detail
Table 71. Triad Isotopes Business Overview
Table 72. Triad Isotopes Nuclear Medicine Product
Table 73. Triad Isotopes Revenue in Nuclear Medicine Business (2017-2022) & (US$ Million)
Table 74. Triad Isotopes Recent Development
Table 75. Nordion Company Detail
Table 76. Nordion Business Overview
Table 77. Nordion Nuclear Medicine Product
Table 78. Nordion Revenue in Nuclear Medicine Business (2017-2022) & (US$ Million)
Table 79. Nordion Recent Development
Table 80. Jubilant Pharma Company Detail
Table 81. Jubilant Pharma Business Overview
Table 82. Jubilant Pharma Nuclear Medicine Product
Table 83. Jubilant Pharma Revenue in Nuclear Medicine Business (2017-2022) & (US$ Million)
Table 84. Jubilant Pharma Recent Development
Table 85. Eli Lilly Company Detail
Table 86. Eli Lilly Business Overview
Table 87. Eli Lilly Nuclear Medicine Product
Table 88. Eli Lilly Revenue in Nuclear Medicine Business (2017-2022) & (US$ Million)
Table 89. Eli Lilly Recent Development
Table 90. SIEMENS Company Detail
Table 91. SIEMENS Business Overview
Table 92. SIEMENS Nuclear Medicine Product
Table 93. SIEMENS Revenue in Nuclear Medicine Business (2017-2022) & (US$ Million)
Table 94. SIEMENS Recent Development
Table 95. China Isotope & Radiation Company Detail
Table 96. China Isotope & Radiation Business Overview
Table 97. China Isotope & Radiation Nuclear MedicineProduct
Table 98. China Isotope & Radiation Revenue in Nuclear Medicine Business (2017-2022) & (US$ Million)
Table 99. China Isotope & Radiation Recent Development
Table 100. Dongcheng Company Detail
Table 101. Dongcheng Business Overview
Table 102. Dongcheng Nuclear MedicineProduct
Table 103. Dongcheng Revenue in Nuclear Medicine Business (2017-2022) & (US$ Million)
Table 104. Dongcheng Recent Development
Table 105. GE Healthcare Company Information
Table 106. GE Healthcare Business Overview
Table 107. GE Healthcare Nuclear Medicine Revenue in Nuclear Medicine Business (2018-2023) & (US$ Million)
Table 108. GE Healthcare Revenue in Nuclear Medicine Business (2018-2023) & (US$ Million) Portfolio
Table 109. GE Healthcare Recent Development
Table 110. Bracco Imaging Company Information
Table 111. Bracco Imaging Business Overview
Table 112. Bracco Imaging Nuclear Medicine Revenue in Nuclear Medicine Business (2018-2023) & (US$ Million)
Table 113. Bracco Imaging Revenue in Nuclear Medicine Business (2018-2023) & (US$ Million) Portfolio
Table 114. Bracco Imaging Recent Development
Table 115. Mallinckrodt Company Information
Table 116. Mallinckrodt Business Overview
Table 117. Mallinckrodt Nuclear Medicine Revenue in Nuclear Medicine Business (2018-2023) & (US$ Million)
Table 118. Mallinckrodt Revenue in Nuclear Medicine Business (2018-2023) & (US$ Million) Portfolio
Table 119. Mallinckrodt Recent Development
Table 120. Lantheus Medical Imaging Company Information
Table 121. Lantheus Medical Imaging Business Overview
Table 122. Lantheus Medical Imaging Nuclear Medicine Revenue in Nuclear Medicine Business (2018-2023) & (US$ Million)
Table 123. Lantheus Medical Imaging Revenue in Nuclear Medicine Business (2018-2023) & (US$ Million) Portfolio
Table 124. Lantheus Medical Imaging Recent Development
Table 125. Bayer Company Information
Table 126. Bayer Business Overview
Table 127. Bayer Nuclear Medicine Revenue in Nuclear Medicine Business (2018-2023) & (US$ Million)
Table 128. Bayer Revenue in Nuclear Medicine Business (2018-2023) & (US$ Million) Portfolio
Table 129. Bayer Recent Development
Table 130. Triad Isotopes Company Information
Table 131. Triad Isotopes Business Overview
Table 132. Triad Isotopes Nuclear Medicine Revenue in Nuclear Medicine Business (2018-2023) & (US$ Million)
Table 133. Triad Isotopes Revenue in Nuclear Medicine Business (2018-2023) & (US$ Million) Portfolio
Table 134. Triad Isotopes Recent Development
Table 135. Nordion Company Information
Table 136. Nordion Business Overview
Table 137. Nordion Nuclear Medicine Revenue in Nuclear Medicine Business (2018-2023) & (US$ Million)
Table 138. Nordion Revenue in Nuclear Medicine Business (2018-2023) & (US$ Million) Portfolio
Table 139. Nordion Recent Development
Table 140. Jubilant Pharma Company Information
Table 141. Jubilant Pharma Business Overview
Table 142. Jubilant Pharma Nuclear Medicine Revenue in Nuclear Medicine Business (2018-2023) & (US$ Million)
Table 143. Jubilant Pharma Revenue in Nuclear Medicine Business (2018-2023) & (US$ Million) Portfolio
Table 144. Jubilant Pharma Recent Development
Table 145. Eli Lilly Company Information
Table 146. Eli Lilly Business Overview
Table 147. Eli Lilly Nuclear Medicine Revenue in Nuclear Medicine Business (2018-2023) & (US$ Million)
Table 148. Eli Lilly Revenue in Nuclear Medicine Business (2018-2023) & (US$ Million) Portfolio
Table 149. Eli Lilly Recent Development
Table 150. SIEMENS Company Information
Table 151. SIEMENS Business Overview
Table 152. SIEMENS Nuclear Medicine Revenue in Nuclear Medicine Business (2018-2023) & (US$ Million)
Table 153. SIEMENS Revenue in Nuclear Medicine Business (2018-2023) & (US$ Million) Portfolio
Table 154. SIEMENS Recent Development
Table 155. China Isotope & Radiation Company Information
Table 156. China Isotope & Radiation Business Overview
Table 157. China Isotope & Radiation Nuclear MedicineRevenue in Nuclear Medicine Business (2018-2023) & (US$ Million)
Table 158. China Isotope & Radiation Revenue in Nuclear Medicine Business (2018-2023) & (US$ Million) Portfolio
Table 159. China Isotope & Radiation Recent Development
Table 160. Dongcheng Company Information
Table 161. Dongcheng Business Overview
Table 162. Dongcheng Nuclear MedicineRevenue in Nuclear Medicine Business (2018-2023) & (US$ Million)
Table 163. Dongcheng Revenue in Nuclear Medicine Business (2018-2023) & (US$ Million) Portfolio
Table 164. Dongcheng Recent Development
Table 165. Authors List of This Report
LIST OF FIGURES
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Nuclear Medicine Product Picture
Figure 5. Global Nuclear Medicine Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 6. Global Nuclear Medicine Market Share by Type: 2022 VS 2029
Figure 7. Tc-99 Product Picture
Figure 8. I-123/131 Product Picture
Figure 9. In-111 Product Picture
Figure 10. Xe-133 Product Picture
Figure 11. Th-201 Product Picture
Figure 12. Ga-67 Product Picture
Figure 13. Others Product Picture
Figure 14. Global Nuclear Medicine Market Size by Application (2023-2029) & (US$ Million)
Figure 15. Global Nuclear Medicine Market Share by Application: 2022 VS 2029
Figure 16. Diagnostic Product Picture
Figure 17. Therapeutic Product Picture
Figure 18. Global Nuclear Medicine Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 19. Global Nuclear Medicine Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 20. Global Nuclear Medicine Market Share by Region: 2022 VS 2029
Figure 21. Global Nuclear Medicine Market Share by Players in 2022
Figure 22. Global Nuclear Medicine Players, Date of Enter into This Industry
Figure 23. Global Top 5 and 10 Nuclear Medicine Players Market Share by Revenue in 2022
Figure 24. Players Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 25. North America Nuclear Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. North America Nuclear Medicine Market Share by Country (2018-2029)
Figure 27. United States Nuclear Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Canada Nuclear Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Europe Nuclear Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Europe Nuclear Medicine Market Share by Country (2018-2029)
Figure 31. Germany Nuclear Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. France Nuclear Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. U.K. Nuclear Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Italy Nuclear Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Russia Nuclear Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Nordic Countries Nuclear Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Asia-Pacific Nuclear Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Asia-Pacific Nuclear Medicine Market Share by Country (2018-2029)
Figure 39. China Nuclear Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Japan Nuclear Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. South Korea Nuclear Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Southeast Asia Nuclear Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. India Nuclear Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Australia Nuclear Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Latin America Nuclear Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Latin America Nuclear Medicine Market Share by Country (2018-2029)
Figure 47. Mexico Nuclear Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Brazil Nuclear Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Middle East & Africa Nuclear Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. Middle East & Africa Nuclear Medicine Market Share by Country (2018-2029)
Figure 51. Turkey Nuclear Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Saudi Arabia Nuclear Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. UAE Nuclear Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. GE Healthcare Revenue Growth Rate in Nuclear Medicine Business (2018-2023)
Figure 55. Bracco Imaging Revenue Growth Rate in Nuclear Medicine Business (2018-2023)
Figure 56. Mallinckrodt Revenue Growth Rate in Nuclear Medicine Business (2018-2023)
Figure 57. Lantheus Medical Imaging Revenue Growth Rate in Nuclear Medicine Business (2018-2023)
Figure 58. Bayer Revenue Growth Rate in Nuclear Medicine Business (2018-2023)
Figure 59. Triad Isotopes Revenue Growth Rate in Nuclear Medicine Business (2018-2023)
Figure 60. Nordion Revenue Growth Rate in Nuclear Medicine Business (2018-2023)
Figure 61. Jubilant Pharma Revenue Growth Rate in Nuclear Medicine Business (2018-2023)
Figure 62. Eli Lilly Revenue Growth Rate in Nuclear Medicine Business (2018-2023)
Figure 63. SIEMENS Revenue Growth Rate in Nuclear Medicine Business (2018-2023)
Figure 64. China Isotope & Radiation Revenue Growth Rate in Nuclear Medicine Business (2018-2023)
Figure 65. Dongcheng Revenue Growth Rate in Nuclear Medicine Business (2018-2023)
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Nuclear Medicine Product Picture
Figure 5. Global Nuclear Medicine Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 6. Global Nuclear Medicine Market Share by Type: 2022 VS 2029
Figure 7. Tc-99 Product Picture
Figure 8. I-123/131 Product Picture
Figure 9. In-111 Product Picture
Figure 10. Xe-133 Product Picture
Figure 11. Th-201 Product Picture
Figure 12. Ga-67 Product Picture
Figure 13. Others Product Picture
Figure 14. Global Nuclear Medicine Market Size by Application (2023-2029) & (US$ Million)
Figure 15. Global Nuclear Medicine Market Share by Application: 2022 VS 2029
Figure 16. Diagnostic Product Picture
Figure 17. Therapeutic Product Picture
Figure 18. Global Nuclear Medicine Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 19. Global Nuclear Medicine Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 20. Global Nuclear Medicine Market Share by Region: 2022 VS 2029
Figure 21. Global Nuclear Medicine Market Share by Players in 2022
Figure 22. Global Nuclear Medicine Players, Date of Enter into This Industry
Figure 23. Global Top 5 and 10 Nuclear Medicine Players Market Share by Revenue in 2022
Figure 24. Players Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 25. North America Nuclear Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. North America Nuclear Medicine Market Share by Country (2018-2029)
Figure 27. United States Nuclear Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Canada Nuclear Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Europe Nuclear Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Europe Nuclear Medicine Market Share by Country (2018-2029)
Figure 31. Germany Nuclear Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. France Nuclear Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. U.K. Nuclear Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Italy Nuclear Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Russia Nuclear Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Nordic Countries Nuclear Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Asia-Pacific Nuclear Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Asia-Pacific Nuclear Medicine Market Share by Country (2018-2029)
Figure 39. China Nuclear Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Japan Nuclear Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. South Korea Nuclear Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Southeast Asia Nuclear Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. India Nuclear Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Australia Nuclear Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Latin America Nuclear Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Latin America Nuclear Medicine Market Share by Country (2018-2029)
Figure 47. Mexico Nuclear Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Brazil Nuclear Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Middle East & Africa Nuclear Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. Middle East & Africa Nuclear Medicine Market Share by Country (2018-2029)
Figure 51. Turkey Nuclear Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Saudi Arabia Nuclear Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. UAE Nuclear Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. GE Healthcare Revenue Growth Rate in Nuclear Medicine Business (2018-2023)
Figure 55. Bracco Imaging Revenue Growth Rate in Nuclear Medicine Business (2018-2023)
Figure 56. Mallinckrodt Revenue Growth Rate in Nuclear Medicine Business (2018-2023)
Figure 57. Lantheus Medical Imaging Revenue Growth Rate in Nuclear Medicine Business (2018-2023)
Figure 58. Bayer Revenue Growth Rate in Nuclear Medicine Business (2018-2023)
Figure 59. Triad Isotopes Revenue Growth Rate in Nuclear Medicine Business (2018-2023)
Figure 60. Nordion Revenue Growth Rate in Nuclear Medicine Business (2018-2023)
Figure 61. Jubilant Pharma Revenue Growth Rate in Nuclear Medicine Business (2018-2023)
Figure 62. Eli Lilly Revenue Growth Rate in Nuclear Medicine Business (2018-2023)
Figure 63. SIEMENS Revenue Growth Rate in Nuclear Medicine Business (2018-2023)
Figure 64. China Isotope & Radiation Revenue Growth Rate in Nuclear Medicine Business (2018-2023)
Figure 65. Dongcheng Revenue Growth Rate in Nuclear Medicine Business (2018-2023)
